Oropharyngeal Dysphagia in Patients With Community Acquired Pneumonia

April 10, 2019 updated by: Dorte Melgaard Kristiansen, Vendsyssel Hospital

This study investigates relationship between community acquired pneumonia and oropharyngeal dysphagia in patients admitted to a department of respiratory medicine in Northern Denmark.

The endpoints will be re-hospitalisation and mortality.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Community acquired pneumonia (CAP) is an important cause of morbidity and mortality in elderly patients. Risk factors are many including oropharyngeal dysphagia (OD). Systematic screening of OD is recommended for at-risk popolations, however these resommandations do not specifically address elderly patients hospitalized with CAP.

In this study OD is assessed in all patients by Volume-Viscosity Swallowing Test (V-VST) The study is registered by the Danish Data Protection Authority (2008-58-0028)

Study Type

Observational

Enrollment (Actual)

154

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Denmark
      • Hjørring, Denmark, 9800
        • Vendsyssel Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Hospitalized patients recruited from the Department of Respiratory Medicine at North Denmeark Regional Hospital.

Description

Inclusion Criteria:

  • Temperature > 38 degrees Celcius
  • New infiltrate on chest x-ray
  • Increased C-reactive protein (CRP)
  • Either cough, dyspnea, pleuritic chest pain, expectoration, or tachypnea

Exclusion Criteria:

  • patients referred from the intensive care unit
  • reduced cognitive awareness if not able to able to cooperate with the assessment of oropharyngeal dysphagia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Pneumonia and dysphagia
Patients with community aquired pneumonia and oropharyngea dysphagia
Other: Dysphagia
Oropharyngeal dysphagia assessed by Volume-Viscosity Svallowing Test
Pneumonia
Patients with community aquired pneumonia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intra Hospital Mortality
Time Frame: With in 10 days from admission
Intra hospital mortality is death while the patient is hospitalized
With in 10 days from admission
30 Day Mortality
Time Frame: 30 days after discharge
Death within 30 days of discharge
30 days after discharge
Re-hospitalization
Time Frame: 30 days after discharge
The rate of re-hospitalization within 30 days of discharge
30 days after discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Vendsyssel Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2013

Primary Completion (ACTUAL)

October 1, 2013

Study Completion (ACTUAL)

March 1, 2014

Study Registration Dates

First Submitted

October 25, 2013

First Submitted That Met QC Criteria

October 31, 2013

First Posted (ESTIMATE)

November 1, 2013

Study Record Updates

Last Update Posted (ACTUAL)

April 24, 2019

Last Update Submitted That Met QC Criteria

April 10, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RHN_DMK_03

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pneumonia

Clinical Trials on Dysphagia

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe